ArticleSustainable cities and society2023
Pandemic vulnerability index of US cities: A hybrid knowledge-based and data-driven approach.
Article in Sustainable cities and society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A retrospective assessment of COVID-19 vulnerability index indicators and mortality rates pre-COVID-19 (2018-2020) and during COVID-19 (2020-2022) in a health and demographic surveillance site, Soweto, South Africa.Population health metrics · 2025Article
- Generative Artificial Intelligence Use in Healthcare: Opportunities for Clinical Excellence and Administrative Efficiency.Journal of medical systems · 2025Article
- Associations between COVID-19 Pandemic, Lockdown Measures and Human Mobility: Longitudinal Evidence from 86 Countries.International journal of environmental research and public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cities become mission-critical zones during pandemics and it is vital to develop a better understanding of the factors that are associated with infection levels. The COVID-19 pandemic has impacted many cities severely; however, there is significant variance in its impact across cities. Pandemic infection levels are associated with inherent features of cities (e.g., population size, density, mobility patterns, socioeconomic condition, and health & environment), which need to be better understood. Intuitively, the infection levels are expected to be higher in big urban agglomerations, but the measurable influence of a specific urban feature is unclear. The present study examines 41 variables and their potential influence on the incidence of COVID-19 infection cases. The study uses a multi-method approach to study the influence of variables, classified as demographic, socioeconomic, mobility and connectivity, urban form and density, and health and environment dimensions. This study develops an index dubbed the pandemic vulnerability index at city level (PVI-CI) for classifying the pandemic vulnerability levels of cities, grouping them into five vulnerability classes, from very high to very low. Furthermore, clustering and outlier analysis provides insights on the spatial clustering of cities with high and low vulnerability scores. This study provides strategic insights into levels of influence of key variables upon the spread of infections, along with an objective ranking for the vulnerability of cities. Thus, it provides critical wisdom needed for urban healthcare policy and resource management. The calculation method for the pandemic vulnerability index and the associated analytical process present a blueprint for the development of similar indices for cities in other countries, leading to a better understanding and improved pandemic management for urban areas, and more resilient planning for future pandemics in cities across the world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.